Chemomab Therapeutics Ltd. - American Depository Shares, each of which represent twenty ordinary shares, no par value (GLTO)

Q: What does CUSIP 36322Q107 represent in this 13F holders report?

CUSIP 36322Q107 is the security identifier for GLTO - Chemomab Therapeutics Ltd. - American Depository Shares, each of which represent twenty ordinary shares, no par value used to aggregate holder disclosures.

Q: How many institutions held GLTO - Chemomab Therapeutics Ltd. - American Depository Shares, each of which represent twenty ordinary shares, no par value in Q3 2024?

No institutional holders were reported for GLTO - Chemomab Therapeutics Ltd. - American Depository Shares, each of which represent twenty ordinary shares, no par value in Q3 2024; review adjacent reporting periods for trend context.

CUSIP: 36322Q107

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / American Depository Shares, each of which represent twenty ordinary shares, no par value
Total 13F shares: 0
Total 13F value: $0
Share change: -4,015,075
Number of holders: 0
Value change: -$1,904,041
Number of sells: 19
Shares outstanding: 7,500,000

Security key

36322Q107

Report period

Q3 2024

Institutions

Top holders

GLTO full security history Chemomab Therapeutics Ltd. SEC filings Chemomab Therapeutics Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

There are no holders of GLTO - Chemomab Therapeutics Ltd. - American Depository Shares, each of which represent twenty ordinary shares, no par value as of Q3 2024.